HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Effect of milrinone on short-term outcome of patients with myocardial dysfunction undergoing coronary artery bypass graft: A randomized controlled trial.

AbstractBACKGROUND:
Myocardial dysfunction needing inotropic support is a typical complication after on-pump cardiac surgery. In this study, we evaluate the effect of milrinone on patients with ventricular dysfunction undergoing coronary artery bypass graft (CABG).
METHODS:
Seventy patients with impaired left ventricular function [left ventricular ejection fraction (LVEF) < 35%] undergoing on-pump CABG were enrolled. Patients were randomized to receive either an intraoperative bolus of milrinone (50 microg/kg) or saline as placebo followed by a 24-hour infusion of each agent (0.5 microg/kg/min). Hemodynamic parameters and transthoracic echocardiographic measurement of systolic and diastolic functions were the variables evaluated.
RESULTS:
Serum levels of creatine phosphokinase (CPK), the MB isoenzyme of creatine kinase (CK-MB), occurrence of myocardial ischemia or infarction, and mean duration of using inotropic agents were significantly lower in the milrinone group (p < 0.05). There were no significant differences between the two groups regarding the development of ventricular arrhythmia, duration of cardiopulmonary bypass, intra-aortic balloon pump and inotropic support requirement, duration of mechanical ventilation, duration of intensive care unit stay and mortality rate. Although mean pre-operative LVEF was significantly lower in the milrinone group, there was no significant difference between post-operative LVEFs.
CONCLUSIONS:
We suggest that perioperative administration of milrinone in patients undergoing on-pump CABG, especially those with low LVEF, is beneficial.
AuthorsMohammad Jebeli, Mohammad Ghazinoor, Mohammad Hussein Mandegar, Mohammad R Rasouli, Payam Eghtesadi-Araghi, Hamidreza Goodarzynejad, Robabeh Mohammadzadeh, Ali Darehzereshki, Saied Dianat
JournalCardiology journal (Cardiol J) Vol. 17 Issue 1 Pg. 73-8 ( 2010) ISSN: 1898-018X [Electronic] Poland
PMID20104460 (Publication Type: Journal Article, Randomized Controlled Trial)
Chemical References
  • Cardiotonic Agents
  • Creatine Kinase
  • Creatine Kinase, MB Form
  • Milrinone
Topics
  • Aged
  • Cardiotonic Agents (administration & dosage)
  • Coronary Artery Bypass
  • Creatine Kinase (blood)
  • Creatine Kinase, MB Form (blood)
  • Drug Administration Schedule
  • Echocardiography
  • Female
  • Humans
  • Incidence
  • Infusions, Intravenous
  • Injections, Intravenous
  • Male
  • Middle Aged
  • Milrinone (administration & dosage)
  • Myocardial Infarction (epidemiology, etiology)
  • Myocardial Ischemia (epidemiology, etiology)
  • Perioperative Care
  • Stroke Volume
  • Time Factors
  • Treatment Outcome
  • Ventricular Dysfunction, Left (diagnostic imaging, drug therapy, physiopathology, surgery)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: